← Browse by Condition
Medical Condition

microbiome

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for microbiome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — microbiome Clinical Trials

How many clinical trials are currently recruiting for microbiome?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for microbiome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for microbiome?
microbiome research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a microbiome clinical trial?
Eligibility criteria for microbiome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Herlev Hospital 1 trial
Jubaan Ltd. 1 trial
University of California, San Diego 1 trial
University of Florida 1 trial

Recruiting Clinical Trials

NCT07250100
Recruiting

The Role of Microbiota in Pancreatic Cancer and Precursor Lesions

Enrollment
300 pts
Location
Denmark
Sponsor
Herlev Hospital
View Trial →
NCT07623902
Recruiting

Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

Enrollment
1,436 pts
Location
United States
Sponsor
Jubaan Ltd.
View Trial →
NCT05514899 Phase 2
Recruiting

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

Enrollment
90 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT06606119
Recruiting

The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma

Enrollment
275 pts
Location
United States
Sponsor
University of Florida
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology